adamantane has been researched along with Hypergonadotropic Hypogonadism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelestimur, H; Sahin, Z | 1 |
| Blomenröhr, M; García-Galiano, D; Gaytan, F; Krajnc-Franken, MA; Leon, S; Manfredi-Lozano, M; Navarro, VM; Pinilla, L; Romero-Ruiz, A; Tena-Sempere, M; van Ingen Schenau, D; van Noort, PI | 1 |
2 other study(ies) available for adamantane and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
RF9: May it be a new therapeutic option for hypogonadotropic hypogonadism?
Topics: Adamantane; Animals; CHO Cells; Cricetinae; Cricetulus; Dipeptides; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Hypogonadism; Hypothalamus; Mice; Models, Biological; Models, Theoretical; Neuropeptides; Rats; Receptors, Kisspeptin-1; Receptors, Neuropeptide | 2019 |
Kisspeptin signaling is indispensable for neurokinin B, but not glutamate, stimulation of gonadotropin secretion in mice.
Topics: Adamantane; Animals; Dipeptides; Follicle Stimulating Hormone; Galanin-Like Peptide; Glutamic Acid; Gonadotropin-Releasing Hormone; Gonadotropins; Hypogonadism; Kisspeptins; Luteinizing Hormone; Male; Mice; Mice, Knockout; Models, Neurological; Naltrexone; Neurokinin B; Peptide Fragments; Receptors, G-Protein-Coupled; Receptors, Kisspeptin-1; Receptors, N-Methyl-D-Aspartate; Receptors, Neuropeptide; Signal Transduction; Substance P; Testosterone | 2012 |